Latest news

ASA issues warning for LED mask advert

Assessing and Managing Infraorbital Hollowing

Treating Facial Burns with Hypochlorous Acid

New drug aims to combat muscle loss in GLP-1 patients

Totally Derma introduces council group

IDENEL Professional partners with Wigmore Medical

Bridgepoint Group acquires Obagi Medical

Advertorial: More, More, More: Embedding Sun Safety into Everyday Aesthetic Practice

mesoestetic launches menopause-focused range

BAMAN partners with Cotofana Anatomy for training event

Treating Migraines with Toxin

November 23, 2020

Written by...

Kate Byng-Hall

Dr Paul Charlson and Dr Vikram Swaminathan explain how botulinum toxin type A can be used to treat chronic migraines

To access this post, you must purchase Aesthetics Journal Membership – Annual Elite Membership, Aesthetics Journal Membership – Annual Enhanced Membership or Aesthetics Journal Membership – Basic Membership.

log in

Share this article:

Quick links:

Most popular:

Bridgepoint Group acquires Obagi Medical

June 10, 2026

Report outlines patient perceptions

June 4, 2026

Special Feature: Optimising Skin Quality with Skin Boosters

June 3, 2026

JCCP clarifies GDC scope of practice guidance

May 30, 2026

Spotting Vulnerable GLP-1 patients

May 20, 2026